drugset / Trial / NCT03664453

A Pharmacokinetic Study of Omaveloxolone in Healthy Volunteers

NCT03664453

Phase 1 Completed 32 enrolled Biogen
RandomizedCrossoverOpen-labelTreatment

Summary

This study will determine the effect of food on the pharmacokinetics of omaveloxolone (150 mg) in healthy adult subjects and will assess the safety, tolerability, and dose proportionality of 50 mg, 100 mg, and 150 mg omaveloxolone in healthy adult subjects. The study will be conducted in two parts, conducted simultaneously. Part 1 will assess the food effect, while Part 2 will assess dose proportionality.

Timeline

Start
2018-10-29
Primary completion
2018-11-20
Completion
2018-11-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Omaveloxolone Small molecule 50 mg
Subject Omaveloxolone Small molecule 100 mg
Subject Omaveloxolone Small molecule 150 mg

Indications

No indication recorded.